Brian Piekos - Net Worth and Insider Trading

Brian Piekos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Piekos owns 3 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Disc Medicine Inc (IRON) , and Elicio Therapeutics Inc (ELTX) .

Click here to see the complete history of Brian Piekos’s form 4 insider trades.

Insider Ownership Summary of Brian Piekos

Ticker	Comapny	Transaction Date	Type of Owner
AMAG	AMAG Pharmaceuticals Inc	2020-06-09	Interim CFO
IRON	Disc Medicine Inc	2021-05-14	Chief Financial Officer
ELTX	Elicio Therapeutics Inc	2023-06-01	Chief Financial Officer

Brian Piekos Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Piekos Ownership Network

Ownership Network List of Brian Piekos

No Data

Ownership Network Relation of Brian Piekos

Brian Piekos Owned Company Details

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Brian Piekos is the Interim CFO of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and director & 10 percent owner David Edward Johnson .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Disc Medicine Inc do?

Who are the key executives at Disc Medicine Inc?

Brian Piekos is the Chief Financial Officer of Disc Medicine Inc. Other key executives at Disc Medicine Inc include 10 percent owner Atlas Venture Fund X, L.p. , director & 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner Mona Ashiya .

Disc Medicine Inc (IRON) Insider Trades Summary

Over the past 18 months, Brian Piekos made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,918 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,918 shares. During the past 18 months, 3,899,867 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,692 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Disc Medicine Inc Insider Transactions

No Available Data

What does Elicio Therapeutics Inc do?

Who are the key executives at Elicio Therapeutics Inc?

Brian Piekos is the Chief Financial Officer of Elicio Therapeutics Inc. Other key executives at Elicio Therapeutics Inc include See Remarks Christopher Haqq , director & CEO & President and Director Robert Connelly , and Chief Business Officer Annette Matthies .

Elicio Therapeutics Inc (ELTX) Insider Trades Summary

Over the past 18 months, Brian Piekos made no insider transaction in Elicio Therapeutics Inc (ELTX). Other recent insider transactions involving Elicio Therapeutics Inc (ELTX) include a net purchase of 1,213,000 shares made by Yekaterina Chudnovsky ,

In summary, during the past 3 months, insiders sold 0 shares of Elicio Therapeutics Inc (ELTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elicio Therapeutics Inc (ELTX) were sold and 1,213,000 shares were bought by its insiders, resulting in a net purchase of 1,213,000 shares.

Elicio Therapeutics Inc (ELTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elicio Therapeutics Inc Insider Transactions

No Available Data

Brian Piekos Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Piekos. You might contact Brian Piekos via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.

Discussions on Brian Piekos

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.